Why NASDAQ:TGTX is Poised for High Growth.

In this article we will dive into TG THERAPEUTICS INC (NASDAQ:TGTX) as a possible candidate for growth investing. Investors should always do their own research, but we noticed TG THERAPEUTICS INC showing up in our Louis Navellier growth screen, which makes it worth to investigate a bit more.

Some of the growth metrics of NASDAQ:TGTX highlighted

• With a solid Return on Equity (ROE) of 53.87%, TG THERAPEUTICS INC exemplifies its ability to generate favorable returns on shareholder investments. This metric demonstrates the company's commitment to maximizing shareholder value.
• TG THERAPEUTICS INC has a strong history of beating EPS estimates 3 times in the last 4 quarters, signaling its ability to consistently exceed market expectations. This indicates the company's strong financial performance and its potential for creating shareholder value.
• With notable 1-year revenue growth of 1.0K%, TG THERAPEUTICS INC exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for future growth.
• TG THERAPEUTICS INC has achieved significant quarter-to-quarter (Q2Q) revenue growth of 357.0%, signaling its ability to capture market opportunities and drive top-line expansion. This growth underscores the company's effective execution and its potential for continued success.
• TG THERAPEUTICS INC has experienced notable growth in its operating margin over the past year, reflecting improved operational performance. This growth suggests the company's ability to generate higher profits from its core business activities.
• TG THERAPEUTICS INC has shown positive growth in its free cash flow (FCF) over the past year, indicating improved cash generation and financial strength. This growth highlights the company's ability to effectively manage its cash flows and generate surplus funds.
• With a favorable trend in its quarter-to-quarter (Q2Q) earnings per share (EPS), TG THERAPEUTICS INC highlights its ability to generate increasing profitability, showcasing a 112.0% growth.
• The average next Quarter EPS Estimate by analysts was adjusted by 329.0%, reflecting the evolving market expectations for the company's EPS growth.
• In the most recent financial report, TG THERAPEUTICS INC reported a 112.0% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
• The earnings per share (EPS) growth of TG THERAPEUTICS INC are accelerating: the current Q2Q growth of 112.0% is above the previous year Q2Q growth of -13.33%. Earnings momentum and acceleration are key for high growth systems.

How does the complete fundamental picture look for NASDAQ:TGTX?

As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.

TGTX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 572 industry peers in the Biotechnology industry. While TGTX has a great health rating, its profitability is only average at the moment. TGTX is growing strongly while it is still valued neutral. This is a good combination! These ratings would make TGTX suitable for growth investing!

Check the latest full fundamental report of TGTX for a complete fundamental analysis.

Our Lois Navellier screen will find you more ideas suited for growth investing.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.